COVID-19 brings along an ever-growing concern for infected patients who have recovered from the acute phase of the viral infection. These individuals are now suffering from the long-term adverse health effects as a result. These long-term complications (aka long COVID-19), have been shown to affect everyone; including the chronically-sick, the healthy, and even the professional athlete. “Long COVID-19 patients show systemic inflammation and persistent symptoms such as fatigue and malaise, profoundly affecting their quality of life” Hyperbaric oxygen therapy (HBOT) has been shown to help the body produce a strong anti-inflammatory response that may be able to help combat Long Covid and provide symptomatic relief. This study evaluated 5 subjects, (2 patients and 3 athletes) undergoing HBOT for 30 sessions and all 5 showed attenuation of inflammatory biomarkers, particularity the 2 athletes. “From this preliminary observation, HBOT could be considered a potential treatment for long COVID-19 patients.” <view study> Read Less

A new landmark study in hyperabric medicine (HBOT) shows that breathing air (21% oxygen) at 1.3 ATA of hyperbaric pressure mobilizes stem cells! Since 2006, it became clear to us that HBOT helps the body to accelerate tissue repair and regeneration by stimulating the release of stem cells in the bone marrow What we did not know is at what pressure level this occurs at. So a team of researchers decided to try and find out and they published their results in this study. They found that a minimal pressure level of 1.3 ATA caused a significant elevation in stem cells. Moreover, the researches did not add extra oxygen into a breathing apparatus, so the results were purely based upon pressure-alone. This landmark study clearly demonstrates that pressure-alone can be a contributing factor to some of the remarkable benefits that have been documented with hyperabric oxygen therapy. More importantly, it shows that these potentially-contributing  benefits can be achieved at lower pressures and without the use of supplemental oxygen. <view study> Read Less

Overactive bladder (OAB) is a disease with symptoms such as feelings of urgency, nocturia, and frequent urination which is usually accompanied by urinary incontinence. This study showed promising benefits from the application of hyperbaric oxygen therapy. Researchers concluded that HBOT may be a new treatment alternative to overactive bladder syndrome <view study> Read Less

The author of this case report followed the results of a 3 month hyperbaric protocol (60 hyperbaric sessions) on himself. Following this simple procedure, he reported receiving improvements in cognition, memory, brain processing speed, athletic performance. Further reports showed an increase in telomere length <view study> Read Less

Oxidative stress is associated with cancer, diabetes, neurodegenerative disorders and more disease processes. Cellular adaptation to oxidative stress is critical for human survival and an important factor related to reducing the course of these progressive diseases. Hyperbaric oxygen therapy is well documented for its role in oxidative regulation and cellular protection. Interestingly, while 1 to 5 consecutive treatments can lead to a reduction in mitochondrial function, 20 to 60 consecutive treatments lead to a significant improvement in mitochondrial parameters <view study> Read Less